Liver metastases from cancer of unknown primary (CUPL): a retrospective analysis of presentation, management and prognosis in 49 patients and systematic review of the literature
dc.contributor.author | Lazaridis, G. | en |
dc.contributor.author | Pentheroudakis, G. | en |
dc.contributor.author | Fountzilas, G. | en |
dc.contributor.author | Pavlidis, N. | en |
dc.date.accessioned | 2015-11-24T19:06:41Z | |
dc.date.available | 2015-11-24T19:06:41Z | |
dc.identifier.issn | 1532-1967 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/20367 | |
dc.rights | Default Licence | - |
dc.subject | Adenocarcinoma/drug therapy/pathology/*secondary | en |
dc.subject | Adult | en |
dc.subject | Aged | en |
dc.subject | Analysis of Variance | en |
dc.subject | Antineoplastic Combined Chemotherapy Protocols/*administration & dosage | en |
dc.subject | Biopsy, Needle | en |
dc.subject | Carcinoma/drug therapy/pathology/*secondary | en |
dc.subject | Female | en |
dc.subject | Humans | en |
dc.subject | Immunohistochemistry | en |
dc.subject | Liver Neoplasms/drug therapy/*secondary | en |
dc.subject | Logistic Models | en |
dc.subject | Lymph Nodes/pathology | en |
dc.subject | Male | en |
dc.subject | Middle Aged | en |
dc.subject | Multivariate Analysis | en |
dc.subject | Neoplasm Staging | en |
dc.subject | Neoplasms, Unknown Primary/drug therapy/*pathology | en |
dc.subject | Probability | en |
dc.subject | Prognosis | en |
dc.subject | Proportional Hazards Models | en |
dc.subject | Retrospective Studies | en |
dc.subject | Risk Assessment | en |
dc.subject | Survival Analysis | en |
dc.subject | Tomography, X-Ray Computed | en |
dc.title | Liver metastases from cancer of unknown primary (CUPL): a retrospective analysis of presentation, management and prognosis in 49 patients and systematic review of the literature | en |
heal.abstract | AIM: Patients with liver metastases from cancer of unknown primary (CUPL) have a dismal prognosis. We retrospectively analysed their management and outcome and performed a systematic review of CUPL series published in the literature. PATIENTS AND METHODS: Electronic data from 49 CUPL patients referred to Hellenic Cooperative Oncology Group (HeCOG) centers were retrospectively studied for characteristics of clinical presentation, diagnostic workup, management, outcome and prognostic factors. A systematic literature review was undertaken in PubMed and EmBase databases. RESULTS: All our patients (males: 31, females: 18; median age: 65) underwent a computed tomography scan (CT) of the abdomen, 71% a thoracic CT, 53% gastroscopy and 47% colonoscopy. The commonest histologic subtypes encountered were adenocarcinoma (N=34) or undifferentiated carcinoma (N=12). The liver was the only metastatic site in 38% of patients, while it was accompanied with other metastatic sites in 62% (the commonest: lung, bone and lymph nodes). Forty-seven patients received first-line chemotherapy (42 platinum based) and 16 second-line. An objective response was observed in six patients (12%), median survival being 10 months (95% CI, 7-13). In univariate analysis, good performance status and normal baseline serum CEA levels were correlated with superior survival, while in multivariate analysis only age<55 (HR 0.16, p=0.02) and the absence of extrahepatic disease (HR 0.21, p=0.007) predicted for a better outcome. Published data from four relevant series (total patients=662) parallel our findings. CONCLUSIONS: Patients with liver metastases from CUP are resistant to conventional types of treatment and carry a poor prognosis. Understanding the molecular biology of CUP is essential for the development of new, targeted effective therapies. | en |
heal.access | campus | - |
heal.fullTextAvailability | TRUE | - |
heal.identifier.primary | 10.1016/j.ctrv.2008.05.005 | - |
heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/18584969 | - |
heal.identifier.secondary | http://ac.els-cdn.com/S0305737208001874/1-s2.0-S0305737208001874-main.pdf?_tid=d717ef7eff37e45df5455e236e7dc813&acdnat=1333954250_ff72ef34704faea11c8497999cd4f735 | - |
heal.journalName | Cancer Treat Rev | en |
heal.journalType | peer-reviewed | - |
heal.language | en | - |
heal.publicationDate | 2008 | - |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
heal.type | journalArticle | - |
heal.type.el | Άρθρο Περιοδικού | el |
heal.type.en | Journal article | en |
Αρχεία
Φάκελος/Πακέτο αδειών
1 - 1 of 1
Φόρτωση...
- Ονομα:
- license.txt
- Μέγεθος:
- 1.74 KB
- Μορφότυπο:
- Item-specific license agreed upon to submission
- Περιγραφή: